Haleon plc (LON:HLN) Insider Buys £124,836.64 in Stock

Haleon plc (LON:HLN) insider Alan Stewart acquired 33,923 shares of the business’s stock in a transaction on Wednesday, November 6th. The stock was acquired at an average price of GBX 368 ($4.79) per share, with a total value of £124,836.64 ($162,505.39).

Haleon Stock Up 0.4 %

LON HLN opened at GBX 363.30 ($4.73) on Friday. The business’s fifty day simple moving average is GBX 383.61 and its 200-day simple moving average is GBX 355.08. The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 54.18. The firm has a market cap of £32.84 billion, a PE ratio of 3,027.50, a P/E/G ratio of 1.49 and a beta of 0.19. Haleon plc has a 52 week low of GBX 308.37 ($4.01) and a 52 week high of GBX 400.65 ($5.22).

Wall Street Analysts Forecast Growth

Separately, Berenberg Bank upped their price target on Haleon from GBX 410 ($5.34) to GBX 447 ($5.82) and gave the company a “buy” rating in a research report on Monday, August 5th.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.